Rankings
▼
Calendar
CMMB Q4 2022 Earnings — Chemomab Therapeutics Ltd. Revenue & Financial Results | Market Cap Arena
CMMB
Chemomab Therapeutics Ltd.
$12M
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$13,962
Operating Income
-$9M
Net Income
-$8M
EPS (Diluted)
$-2.84
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$43M
Total Liabilities
$7M
Stockholders' Equity
$36M
Cash & Equivalents
$14M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$13,962
-$11,050
-26.4%
Operating Income
-$9M
-$5M
-72.0%
Net Income
-$8M
-$5M
-64.3%
← FY 2022
All Quarters
Q1 2023 →